Although basal levels of p-AKT were decreased in the presence of TGF-α compared with vehicle treatment, further inhibition of p-AKT with PX-866 resulted in a significant reduction in SOX9 levels in IPF fibroblasts treated with TGF-α (Figure 2C). Here, AKT1 is linked to idiopathic pulmonary fibrosis.